Logo image of ICUI

ICU MEDICAL INC (ICUI) Stock Price, Forecast & Analysis

USA - NASDAQ:ICUI - US44930G1076 - Common Stock

142.34 USD
+8.01 (+5.96%)
Last: 11/21/2025, 8:00:02 PM
142.34 USD
0 (0%)
After Hours: 11/21/2025, 8:00:02 PM

ICUI Key Statistics, Chart & Performance

Key Statistics
Market Cap3.51B
Revenue(TTM)2.38B
Net Income(TTM)-36.95M
Shares24.69M
Float23.97M
52 Week High175.51
52 Week Low107
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)7.96
PE17.88
Fwd PE17.34
Earnings (Next)02-25 2026-02-25/amc
IPO1992-03-31
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


ICUI short term performance overview.The bars show the price performance of ICUI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

ICUI long term performance overview.The bars show the price performance of ICUI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60

The current stock price of ICUI is 142.34 USD. In the past month the price increased by 15.27%. In the past year, price decreased by -15.51%.

ICU MEDICAL INC / ICUI Daily stock chart

ICUI Latest News, Press Relases and Analysis

ICUI Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
COO COOPER COS INC/THE 18.77 15.00B
SOLV SOLVENTUM CORP 13.96 14.37B
ALGN ALIGN TECHNOLOGY INC 14.74 10.33B
MMSI MERIT MEDICAL SYSTEMS INC 23.44 5.16B
LNTH LANTHEUS HOLDINGS INC 9.37 3.80B
HAE HAEMONETICS CORP/MASS 16.41 3.80B
XRAY DENTSPLY SIRONA INC 6.7 2.11B
UFPT UFP TECHNOLOGIES INC 25.49 1.70B
STAA STAAR SURGICAL CO N/A 1.38B
NEOG NEOGEN CORP 19.07 1.24B
EMBC EMBECTA CORP 4.99 852.20M
BVS BIOVENTUS INC - A 12.27 598.60M

About ICUI

Company Profile

ICUI logo image ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

Company Info

ICU MEDICAL INC

951 Calle Amanecer

San Clemente CALIFORNIA 92763 US

CEO: Vivek Jain

Employees: 15000

ICUI Company Website

ICUI Investor Relations

Phone: 19493662183

ICU MEDICAL INC / ICUI FAQ

What does ICU MEDICAL INC do?

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.


What is the stock price of ICU MEDICAL INC today?

The current stock price of ICUI is 142.34 USD. The price increased by 5.96% in the last trading session.


Does ICU MEDICAL INC pay dividends?

ICUI does not pay a dividend.


What is the ChartMill technical and fundamental rating of ICUI stock?

ICUI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What do analysts say about ICU MEDICAL INC (ICUI) stock?

12 analysts have analysed ICUI and the average price target is 177.68 USD. This implies a price increase of 24.83% is expected in the next year compared to the current price of 142.34.


Can you provide the sector and industry classification for ICU MEDICAL INC?

ICU MEDICAL INC (ICUI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is ICU MEDICAL INC worth?

ICU MEDICAL INC (ICUI) has a market capitalization of 3.51B USD. This makes ICUI a Mid Cap stock.


ICUI Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ICUI. When comparing the yearly performance of all stocks, ICUI turns out to be only a medium performer in the overall market: it outperformed 42.3% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ICUI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ICUI. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ICUI Financial Highlights

Over the last trailing twelve months ICUI reported a non-GAAP Earnings per Share(EPS) of 7.96. The EPS increased by 40.14% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.9%
ROE -1.75%
Debt/Equity 0.63
Chartmill High Growth Momentum
EPS Q2Q%27.67%
Sales Q2Q%-8.85%
EPS 1Y (TTM)40.14%
Revenue 1Y (TTM)5.44%

ICUI Forecast & Estimates

12 analysts have analysed ICUI and the average price target is 177.68 USD. This implies a price increase of 24.83% is expected in the next year compared to the current price of 142.34.

For the next year, analysts expect an EPS growth of 14.6% and a revenue growth -5.53% for ICUI


Analysts
Analysts83.33
Price Target177.68 (24.83%)
EPS Next Y14.6%
Revenue Next Year-5.53%

ICUI Ownership

Ownership
Inst Owners113.8%
Ins Owners0.98%
Short Float %6.31%
Short Ratio5.37